Key result
The SLAC prognostic score predicted atrial fibrillation recurrence at 6 months after successful external electrical cardioversion with good discrimination (c-statistic 0.74; 95% CI 0.69-0.79).
Why the study?
AF recurrence after successful external electrical cardioversion is common, making assessment of individual recurrence risk critical to treatment planning.
Can the SLAC score predict atrial fibrillation recurrence at 6 months in patients who underwent successful external electrical cardioversion?
Cohort
Can the SLAC score predict atrial fibrillation recurrence at 6 months in patients who underwent successful external electrical cardioversion?
Effect estimate: c-statistic 0.74 (95% CI 0.69-0.79)
The SLAC score provides a simple, internally validated 14-point tool to stratify the risk of atrial fibrillation recurrence after successful electrical cardioversion.
May aid post-cardioversion AF risk stratification; leaves open external validation before clinical adoption.
INTRODUCTION: Atrial fibrillation (AF) recurrence after a successful external electrical cardioversion (ECV) is common. Assessing an individual's risk of AF recurrence is a critical part of the treatment plan. We aimed to develop a prognostic prediction score to predict AF recurrence in AF patients who underwent successful ECV. METHODS: A retrospective cohort study that included AF patients who underwent successful ECV was conducted with a primary outcome of AF recurrence at 6 months. Logistic regression analysis was done to identify variables, and a prognostic prediction score was created and internally validated. RESULTS: Four prognostic predictors were identified, including the type of AF, persistent AF (1 point) and long-standing persistent AF (4 points), previous cardioversion (1 point), stroke/transient ischemic attack (3 points), and left atrial volume index ≥40 mL/m 2 (6 points). The total score of 14 was further divided into 3 risk groups; low-risk (0-2 points), moderate-risk (3-7 points), and high-risk (8-14 points). The positive likelihood ratio for a moderate-risk patient was 2.08 (95% CI, 1.64-2.63) and for a high-risk patient was 7.90 (95% CI, 2.48-25.17). The score showed good discrimination power with the c-statistic of 0.74 (95% CI, 0.69-0.79). CONCLUSIONS: A simple prognostic prediction score for AF recurrence after successful ECV was created with a promising internally validated discrimination power. An external assessment of its usefulness as a tool to identify patients with low, moderate, and high risk for AF recurrence is warranted.
No takes yet. Share an insight, caveat, or question.
Thangjui et al. (2022) conducted a cohort in Atrial fibrillation. SLAC Score was evaluated on Atrial fibrillation recurrence at 6 months (c-statistic 0.74, 95% CI 0.69-0.79). The SLAC prognostic score predicted atrial fibrillation recurrence at 6 months after successful external electrical cardioversion with good discrimination (c-statistic 0.74; 95% CI 0.69-0.79).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: